|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Kidney Disease | |||||
| Albuminuria | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Kidney Diseases | |||||
| Kidney Failure, Chronic | |||||
| 3 | More general conditions related to this trial | ||||
| Kidney Failure | |||||
| Proteinuria | |||||
| Renal Insufficiency | |||||
| Renal Insufficiency, Chronic | |||||
| Signs and Symptoms | |||||
| Urination Disorders | |||||
| Urologic Diseases | |||||
| Urological Manifestations | |||||
| 4 | Interventions listed in this trial | ||||
| Tetrahydrobiopterin (6R BH4) | |||||
| 5 | Sponsors listed in this trial | ||||
| University of Michigan | |||||
| BioMarin Pharmaceutical | |||||